These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 19357525

  • 1. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L, Astuto M, Vecchio I, Rampello L.
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [Abstract] [Full Text] [Related]

  • 2. Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial.
    Malaguarnera M, Pistone G, Astuto M, Vecchio I, Raffaele R, Lo Giudice E, Rampello L.
    Dig Dis Sci; 2006 Dec; 51(12):2242-7. PubMed ID: 17080254
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [Abstract] [Full Text] [Related]

  • 4. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
    Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario E, Fabbri A, Pisi E.
    Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
    [Abstract] [Full Text] [Related]

  • 5. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
    Les I, Doval E, García-Martínez R, Planas M, Cárdenas G, Gómez P, Flavià M, Jacas C, Mínguez B, Vergara M, Soriano G, Vila C, Esteban R, Córdoba J.
    Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
    Caballería Rovira E, Arago López JV, Masso Ubeda RM, Vidal Clemente JL, Sanchís Closa A.
    Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
    [No Abstract] [Full Text] [Related]

  • 7. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status.
    Kawamura E, Habu D, Morikawa H, Enomoto M, Kawabe J, Tamori A, Sakaguchi H, Saeki S, Kawada N, Shiomi S.
    Liver Transpl; 2009 Jul; 15(7):790-7. PubMed ID: 19562716
    [Abstract] [Full Text] [Related]

  • 8. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G, Giguère JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF.
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [Abstract] [Full Text] [Related]

  • 9. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G, Di Lorenzo G, Soldini M, Marziali M, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Barbarini G.
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [Abstract] [Full Text] [Related]

  • 10. Prospective randomized controlled study of short-term perioperative oral nutrition with branched chain amino acids in patients undergoing liver surgery.
    Ishikawa Y, Yoshida H, Mamada Y, Taniai N, Matsumoto S, Bando K, Mizuguchi Y, Kakinuma D, Kanda T, Tajiri T.
    Hepatogastroenterology; 2010 Jun; 57(99-100):583-90. PubMed ID: 20698232
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
    Kanematsu T, Koyanagi N, Matsumata T, Kitano S, Takenaka K, Sugimachi K.
    Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
    [Abstract] [Full Text] [Related]

  • 13. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, Muraoka T, Honda T, Otani M, Akiyama M, Miuma S, Ozawa E, Fujimito M, Eguchi K.
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [Abstract] [Full Text] [Related]

  • 14. Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy.
    Siciliano M, Annicchiarico BE, Lucchese F, Bombardieri G.
    Clin Exp Pharmacol Physiol; 2006 Feb; 33(1-2):76-80. PubMed ID: 16445703
    [Abstract] [Full Text] [Related]

  • 15. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T, Nagai H, Kanayama M, Sumino Y.
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [Abstract] [Full Text] [Related]

  • 16. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF, el Younsi M, Pidoux B, Zylberberg P, Benhamou Y, Valla D, Opolon P.
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
    Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P.
    Liver Int; 2010 Apr; 30(4):574-82. PubMed ID: 20456040
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis.
    Togo S, Tanaka K, Morioka D, Sugita M, Ueda M, Miura Y, Kubota T, Nagano Y, Matsuo K, Endo I, Sekido H, Shimada H.
    Nutrition; 2005 Apr; 21(4):480-6. PubMed ID: 15811769
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
    Bauer AG, Wilson JH, Lamberts SW, Blom W.
    Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.